JENNIFER NAVARRO: Open Payments
NPI 1750876496 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 38 payments from 16 companies in 2025. Trend: 2023 $250 · 2024 $382 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $190 |
| Supernus Pharmaceuticals, Inc. | 6 | $117 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Corium, LLC | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
Products named: FREESTYLE LIBRE 3, Qelbree, CAPLYTA, HETLIOZ, INGREZZA, Azstarys, SPRAVATO, VRAYLAR.
Industry payments across FL — which companies pay providers there.
